14th annual Controlled Release Delivery London, England, UK 3-4 April 2017

Description:
Aimed at drug development experts and formulation specialists, Controlled Release Delivery 2017 will reflect on the latest innovations made within controlled release.

Drug delivery methods include oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable and transmucosal. With oral being the largest segment, controlled-release drug-delivery systems continue to play an important role in the treatment of diseases.

With a carefully selected panel of industry experts, the 2017 event will address the latest regulatory updates and how to overcome challenges within the industry. Key topics that will be explored include: innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.

SPEAKER LINE UP
CHAIRMEN:
• Howard Stevens, Professor, University Of Strathclyde
• Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research

FEATURED SPEAKERS:
• Markham Luke, Director, Division of Therapeutic Performance, FDA
• René Holm, Head and Scientific Director, Liquids & Parenterals, Janssen
• Mark Wilson, Director, Technology Licensing, PTS, GSK
• Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
• Stephan Buchmann, Head Preformulation & Preclinical Galenics, Actelion
• John Fox, Chief Executive Officer, Merrion Pharmaceuticals
• and many more...

Prices:
BOOK BY 16TH DEC 2016: GBP 1099
BOOK BY 31ST JAN 2017: GBP 1299
BOOK BY 28TH FEB 2017: GBP 1399
FROM 1ST MARCH 2017: GBP 1499